These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27732771)

  • 1. N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.
    O'Sullivan JM; Aguila S; McRae E; Ward SE; Rawley O; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Chion A; O'Donnell JS
    J Thromb Haemost; 2016 Dec; 14(12):2446-2457. PubMed ID: 27732771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor sialylation-A critical regulator of biological function.
    Ward S; O'Sullivan JM; O'Donnell JS
    J Thromb Haemost; 2019 Jul; 17(7):1018-1029. PubMed ID: 31055873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.
    Chion A; O'Sullivan JM; Drakeford C; Bergsson G; Dalton N; Aguila S; Ward S; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Laffan M; McKinnon TA; O'Donnell JS
    Blood; 2016 Oct; 128(15):1959-1968. PubMed ID: 27554083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance.
    Ward SE; O'Sullivan JM; Moran AB; Spencer DIR; Gardner RA; Sharma J; Fazavana J; Monopoli M; McKinnon TAJ; Chion A; Haberichter S; O'Donnell JS
    Haematologica; 2022 Mar; 107(3):668-679. PubMed ID: 33763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI.
    Atiq F; Rawley O; O'Sullivan JM; Özbil M; Doherty D; Cooke N; Terraube V; Chion A; Amin A; Hulshof AM; Baci B; Byrne C; Aburawi HE; Lillicrap D; O'Donnell JS
    J Thromb Haemost; 2024 Oct; 22(10):2752-2760. PubMed ID: 38996914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased galactose expression and enhanced clearance in patients with low von Willebrand factor.
    Aguila S; Lavin M; Dalton N; Patmore S; Chion A; Trahan GD; Jones KL; Keenan C; Brophy TM; O'Connell NM; Ryan K; Byrne M; Nolan M; Patel A; Preston RJS; James P; Di Paola J; O'Sullivan JM; O'Donnell JS
    Blood; 2019 Apr; 133(14):1585-1596. PubMed ID: 30770394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo.
    Rawley O; O'Sullivan JM; Chion A; Keyes S; Lavin M; van Rooijen N; Brophy TM; Fallon P; Preston RJ; O'Donnell JS
    J Thromb Haemost; 2015 May; 13(5):821-6. PubMed ID: 25690668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS-13 glycans and conformation-dependent activity.
    Nowak AA; O'Brien HER; Henne P; Doerr A; Vanhoorelbeke K; Laffan MA; McKinnon TAJ
    J Thromb Haemost; 2017 Jun; 15(6):1155-1166. PubMed ID: 28370891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the clearance of VWF A-domains using site-directed PEGylation and novel N-linked glycosylation.
    Fazavana J; Brophy TM; Chion A; Cooke N; Terraube V; Cohen J; Parng C; Pittman D; Cunningham O; Lambert M; O'Donnell JS; O'Sullivan JM
    J Thromb Haemost; 2020 Jun; 18(6):1278-1290. PubMed ID: 32108991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biological Significance of von Willebrand Factor O-Linked Glycosylation.
    Ward S; O'Sullivan JM; O'Donnell JS
    Semin Thromb Hemost; 2021 Oct; 47(7):855-861. PubMed ID: 34130346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
    Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
    Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.
    Ward SE; O'Sullivan JM; Drakeford C; Aguila S; Jondle CN; Sharma J; Fallon PG; Brophy TM; Preston RJS; Smyth P; Sheils O; Chion A; O'Donnell JS
    Blood; 2018 Feb; 131(8):911-916. PubMed ID: 29282218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13.
    McGrath RT; McKinnon TA; Byrne B; O'Kennedy R; Terraube V; McRae E; Preston RJ; Laffan MA; O'Donnell JS
    Blood; 2010 Apr; 115(13):2666-73. PubMed ID: 19965639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.
    Wohner N; Legendre P; Casari C; Christophe OD; Lenting PJ; Denis CV
    J Thromb Haemost; 2015 May; 13(5):815-20. PubMed ID: 25728415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet von Willebrand factor--structure, function and biological importance.
    McGrath RT; McRae E; Smith OP; O'Donnell JS
    Br J Haematol; 2010 Mar; 148(6):834-43. PubMed ID: 20067560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis.
    McGrath RT; van den Biggelaar M; Byrne B; O'Sullivan JM; Rawley O; O'Kennedy R; Voorberg J; Preston RJ; O'Donnell JS
    Blood; 2013 Dec; 122(25):4107-10. PubMed ID: 24106205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.
    Canis K; McKinnon TA; Nowak A; Panico M; Morris HR; Laffan M; Dell A
    J Thromb Haemost; 2010 Jan; 8(1):137-45. PubMed ID: 19874459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies.
    Karampini E; Doherty D; Bürgisser PE; Garre M; Schoen I; Elliott S; Bierings R; O'Donnell JS
    Blood Adv; 2024 Jun; 8(12):3254-3266. PubMed ID: 38640438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.
    Nowak AA; McKinnon TA; Hughes JM; Chion AC; Laffan MA
    J Thromb Haemost; 2014 Jan; 12(1):54-61. PubMed ID: 24406064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.